Skip to main content

Table 1 Demographics and baseline characteristics of patients with COVID-19

From: Correlation analysis between disease severity and clinical and biochemical characteristics of 143 cases of COVID-19 in Wuhan, China: a descriptive study

  No. (%)    P Value a
Total(N = 143) Mild/Moderate (n = 72) Severe/Critical(n = 71)
Age, median (IQR), y 58 (39–67) 44 (32–60) 65 (53–69) 0.000
Sex     0.009
 Female 70 (49.0) 43 (59.7) 27 (38.0)
 Male 73 (51.0) 29 (40.3) 44 (62.0)  
Huanan Seafood Wholesale Market exposure 11 (7.7) 4 (5.6) 7 (9.7) 0.359
Comorbidities 50 (35.0) 10 (13.9) 40 (56.3) 0.000
 Hypertension 36 (25.2) 5 (6.9) 31 (43.7) 0.000
 Cardiovascular disease 16 (11.2) 4 (5.6) 12 (16.9) 0.031
 Diabetes 13 (9.1) 4 (5.6) 9 (12.7) 0.139
 Chronic obstructive pulmonary disease 10 (7.0) 3 (4.2) 7 (9.9) 0.091
 Cerebrovascular disease 5 (3.5) 2 (2.8) 3 (4.2) 0.987
Signs and symptoms
 Fever 137 (95.8) 70 (97.2) 67 (94.4) 0.619
 Fatigue 93 (65.0) 42 (58.3) 51 (71.8) 0.091
 Dry cough 78 (54.5) 37 (51.4) 41 (57.7) 0.455
 Anorexia 66 (46.2) 23 (31.9) 43 (60.6) 0.001
 Chest tightness 63 (44.1) 29 (40.3) 34 (47.9) 0.359
 Myalgia 49 (34.3) 18 (25.0) 31 (43.7) 0.019
 Mild shortness of breath 48 (33.6) 33 (45.8) 15 (21.1) 0.002
 Chill 33 (23.1) 19 (26.4) 14 (19.7) 0.344
 Dyspnea 31 (21.7) 10 (13.9) 21 (29.6) 0.023
 Pharyngalgia 28 (19.6) 12 (16.7) 16 (22.5) 0.377
 Diarrhea 26 (18.2) 12 (16.7) 14 (19.7) 0.636
 Expectoration 22 (15.4) 5 (6.9) 17 (23.9) 0.005
 Nausea or Vomiting 14 (9.8) 7 (9.7) 7 (9.9) 0.978
 Headache 7 (4.9) 3 (4.2) 4 (5.6) 0.985
Multiple lung lobe or bilateral involvement 138 (96.5) 68 (94.4) 70 (98.6) 0.371
Onset of symptom to Hospital admission, median (IQR), d 5 (3–7) 4 (3–5) 6 (5–7) 0.000
  1. Abbreviations: IQR interquartile range, COVID-19 Coronavirus disease 2019
  2. aP values indicate differences between mild/moderate and severe/critical. P < 0.05 was considered statistically significant